Floatz logo

Cladribine

Elderly Patients

Sun Yat-sen UniversitySmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

16 Active assets in the Elderly Patients cohort.

Asset / SponsorPhaseRating
Capecitabine
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 3B
NORETHANDROLONE
University Hospital, Grenoble
Phase 3B
ROPIVACAINE
University Hospital, Clermont-Ferrand
Phase 2B
Cyclophosphamide
Fondazione Italiana Linfomi - ETS
Phase 3B
VITAMIN D
Fondazione Italiana Linfomi - ETS
Phase 3B

View all 26 →

Same molecule, other indications

Cladribine is also rated in:

relapsing-remitting multiple sclerosisDormant
BBB
Indicative ·
76 / 100
View asset →
lymphoblastic lymphomaDormant
BBB
Indicative ·
75 / 100
View asset →
multiple sclerosisDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →